Regulating impact on bystanders in clinical trials: An unsettled frontier

Nir Eyal, Jonathan Kimmelman, Lisa G. Holtzman, Marc Lipsitch

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

This article informally reviews key research ethics guidelines and regulations, academic scholarship, and research studies and finds wide variety in how they consider risk to bystanders in medical research (namely, non-participants whom studies nevertheless place at risk). Some of these key sources give no or very little consideration to bystanders, while others offer them the utmost protection (greater than they offer study participants). This unsettled frontier would benefit from a deeper investigation of the ethics of protecting research bystanders.

Original languageEnglish (US)
Pages (from-to)450-454
Number of pages5
JournalClinical Trials
Volume16
Issue number5
DOIs
StatePublished - Oct 1 2019

All Science Journal Classification (ASJC) codes

  • Pharmacology

Keywords

  • Research ethics
  • bystander
  • clinical ethics
  • clinical trials
  • human research subject protection
  • research nonparticipant
  • third party consent

Fingerprint

Dive into the research topics of 'Regulating impact on bystanders in clinical trials: An unsettled frontier'. Together they form a unique fingerprint.

Cite this